Brennan Kevin M.

SVP, FINANCE AND ACCOUNTING at XLO

Sold, on record
$3k
Dollars the filings state
Form 4 sales
2
Latest Jan 2, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XLOXilio Therapeutics, Inc.SVP, FINANCE AND ACCOUNTING

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale XLORoutine
    Jan 2, 2025 2025

    Sold 1,803 shares at $0.98 ($2k)

    Brennan Kevin M., SVP, FINANCE AND ACCOUNTING

    10b5-1 planSold 36.1% of holdings ($5k position)3,197 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale XLORoutine
    Jan 2, 2026 +365 days

    Sold 1,826 shares at $0.64 ($1k)

    Brennan Kevin M., SVP, FINANCE AND ACCOUNTING

    10b5-1 planSold 22.3% of holdings ($5k position)6,371 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Brennan Kevin M.
Source
Jan 2, 2026Jan 5, 2026XLOSVP, FINANCE AND ACCOUNTINGForm 4 sale1,826$1k22.3%RoutineSEC
Jan 2, 2025Jan 3, 2025XLOSVP, FINANCE AND ACCOUNTINGForm 4 sale1,803$2k36.1%RoutineSEC